Skip to content

Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.

The EDFI-Cohort: Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Curative Surgery for Rectal Cancer.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03257332
Acronym
EDFI-Cohort
Enrollment
0
Registered
2017-08-22
Start date
2019-11-12
Completion date
2022-12-31
Last updated
2020-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal Incontinence, Low Anterior Resection Syndrome, Quality of Life, Rectum Cancer

Keywords

Rectum cancer, Low Anterior Rectal Syndrome, Anorectal muscle function

Brief summary

Background: Patients treated for rectal cancer are in high risk of developing poor quality of life and faecal incontinence. Faecal incontinence has a negative impact on quality of life. However, there is limited knowledge on how to prevent it. Known exposures are ; age at surgery, gender, tumor height, pre-operative radiotherapy, surgical technique and temporary stoma. In order to evaluate the underlying mechanisms of faecal incontinence, it is central to evaluate the anorectal muscle function for sensory and motor impairment. Exposures representing different constructs in the biopsychosocial model are likewise likely to be associated with quality of life and faecal incontinence. These exposures include sexual dysfunction, urinary incontinence, fatique, physical inactivity and finding meaning in life. There are to our knowledge, no records on these relationships from prior to surgery to 2 years after. These biopsychosocial exposures are central to include when developing strategies that can prevent poor quality of life and faecal incontinence for patients treated for rectal cancer. Purpose: The primary purpose of the EDFI-Cohort study is to determine how several variables (surgical technique, anorectal muscle function, faecal incontinence, urinary incontinence, sexual dysfunction, fatigue, physical activity and finding meaning in life) develop over time and predicts quality of life. Secondary how it predicts LARS-score in patients with rectal cancer from prior to surgery to 2 years after primary treatment. Methods: We will include subjects diagnosed with rectal cancer and have received curative surgery (low anterior resection) with/without adjuvant (radiation/chemo) therapy. The cohort aim to recruit all eligible patients in a one year period. We estimate to recruit 70 patients. Self-reported outcomes will be collected with a series of validated questionnaires that subjects will be asked to complete 6 times during the two year study at 3, 6, 12, 26 78 and 104 weeks. Outcomes include: Quality of life using (EORTC QLQ-C30) (primary outcome), (CR29) and (FA12), bowel related quality of life (LARS-score) (secondary outcome), faecal incontinence (Vaizey score), urinary incontinence (ICIQ-UI), (MLUTS/FLUTS) and (MLUTSsex/FLUTSsex), physical activity level from Danish National Health Profile and finding meaning in life (SOME). Objective measures will be collected at 6 weeks, 6 months, 12 months and 24 months and include: Anorectal manometry that measures anorectal muscle function and rectal perception, a digital examination of anorectal muscle function using the Digital Rectal Examination Scoring System (DRESS) and the six-minute walk test a measure of submaximal exercise capacity. We plan to analyze the EDFI-Cohort study as repeated measures with both simple and multiple linear regression models for the continuous data. We plan to adjust for known confounders and variables related to treatment.

Interventions

PROCEDURELow Anterior Resection for Rectum Cancer

Subjects should have received curative surgery for rectal cancer (low anterior resection) with/with-out adjuvant (radiation/chemo) therapy.

Sponsors

Zealand University Hospital
CollaboratorOTHER
Association of Danish Physiotherapists
CollaboratorOTHER
Slagelse Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of rectal cancer * Low anterior resection (e.g. not limited to total mesorectal excision (TME) or partial mesorectal excision (PME)) * Ability to communicate in Danish * Adults (\> 18 years of age) * American Society of Anaesthesiologists (ASA) score: I-IV.

Exclusion criteria

* ASA score of: V-VI.

Design outcomes

Primary

MeasureTime frameDescription
Global health status/quality of life: EORTC QLQ-C30104 weeksEuropean Organisation for Research and Treatment of Cancer's generic core set on quality of life (EORTC QLQ-C30)

Secondary

MeasureTime frameDescription
Low anterior resection syndrome104 weeksSelf-reported questionnaire - Low anterior resection symptom - score (LARS-score)

Other

MeasureTime frameDescription
Urinary incontinence - Sexual dysfunction3, 6, 12, 26, 52 and 104 weeksInternational Consultation on Incontinence Questionnaire - Male/female Sexual Matters associated with Lower Urinary Tract Symptoms (ICIQ-MLUTSsex or ICIQ-FLUTSsex)
Global health status/quality of life: EORTC QLQ-C303, 6, 12, 26 and 52 weeksEuropean Organisation for Research and Treatment of Cancer's generic core set on quality of life (EORTC QLQ-C30)
Other subscales than 'global health status/quality of life': EORTC QLQ-C303, 6, 12, 26, 52 and 104 weeksEuropean Organisation for Research and Treatment of Cancer's generic core set on quality of life (EORTC QLQ-C30)
Quality of life - colorectal cancer: EORTC QLQ-CR293, 6, 12, 26, 52 and 104 weeksEuropean Organisation for Research and Treatment of Cancer's colorectal cancer module (EORTC QLQ-CR29)
Quality of life - Fatigue: EORTC QLQ-FA123, 6, 12, 26, 52 and 104 weeksEuropean Organisation for Research and Treatment of Cancer's fatigue module (EORTC QLQ-FA12)
Quality of life - INFO: EORTC QLQ-INFO253, 6, 12, 26, 52 and 104 weeksEuropean Organisation for Research and Treatment of Cancer's information about disease and treatment module (EORTC QLQ-INFO25)
Anorectal muscle function - digital examination6, 26, 52 and 104 weeksMaximal resting pressure Maximal squeeze pressure Endurance squeeze - max squeeze pressure or longest time Latency (rate of force development), number of rectal muscle contractions/squeezes in 15 sec test.
Urinary incontinence3, 6, 12, 26, 52 and 104 weeksInternational Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF)
Anorectal Manometry - capacity6, 26, 52 and 104 weeksVolume capacity measurements: Maximal tolerated volume Conscious rectal sensitivity threshold Conscious rectal sensitivity Constant sensation
Faecal incontinence3, 6, 12, 26, 52 and 104 weeksSelf-reported questionnaire - St. Marks Incontinence score (Vaizey score)
Low anterior resection syndrome3, 6, 12, 26 and 52 weeksSelf-reported questionnaire - Low anterior resection symptom - score (LARS-score)
Physical activity level3, 6, 12, 26, 52 and 104 weeksphysical activity section of the Danish National Health Profile
Finding meaning in life3, 6, 12, 26, 52 and 104 weeksSources of Meaning and Meaning in Life Questionnaire (SoMe)
Physical performance6, 26, 52 and 104 weeks6-Minute Walk test
Anorectal Manometry - pressure6, 26, 52 and 104 weeksMaximal resting pressure Maximal squeeze pressure Maximal squeeze pressure duration
Urinary incontinence - Urinary symptoms3, 6, 12, 26, 52 and 104 weeksInternational Consultation on Incontinence Questionnaire - Male/female Lower Urinary Tract Symptoms (ICIQ-MLUTS og ICIQ-FLUTS)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026